MedPath

A clinical study to compare the the sedative drug combination dexmedetomidine plus ketamine and midazolam plus ketamine on patients undergoing short surgical procedures.

Phase 4
Not yet recruiting
Conditions
Abnormal uterine and vaginal bleeding, unspecified, (2) ICD-10 Condition: K929||Disease of digestive system, unspecified, (3) ICD-10 Condition: N359||Urethral stricture, unspecified,
Registration Number
CTRI/2021/08/035523
Lead Sponsor
Dr Seethal Ann Sunny
Brief Summary

This study is a prospective, double blinded randomised controlled study comparing the effect of intravenous ketamine hydrochloride plus dexmedetomidine hydrochloride and intravenous ketamine hydrochloride plus midazolam hydrochloride in procedural sedation for short surgical procedures.  different drug combinations have been used for sedation in short surgical procedures. Here we tried to compare two drug combinations and try to find out a superior combination which would provide adequate sedation, hemodynamic stability and less postoperative complications.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Consent to participate in study ASA physical Grade 1 and 2 Patients undergoing short surgical procedures.

Exclusion Criteria
  • Patients refusal.
  • Pregnancy and lactating women.
  • History of any significant pulmonary, cardiovascular, neurological, hepatoreanal or metabolic disease.
  • chronic use or addiction to opiates or sedatives.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
we expect that dexmedetomidine plus ketamine will provide adequate depth of anaesthesia and more stable hemodynamic variables.20 weeks
Secondary Outcome Measures
NameTimeMethod
We expect dexmedetomidine plus ketamine to provide less incidence of postoperative complications20 weeks

Trial Locations

Locations (1)

GR Medical College Gwalior

🇮🇳

Gwalior, MADHYA PRADESH, India

GR Medical College Gwalior
🇮🇳Gwalior, MADHYA PRADESH, India
Dr Seethal Ann Sunny
Principal investigator
9495280289
seethalannsunny92@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.